Clinical Laserthermia Systems AB (publ) (?the company?) announced that it has received its second order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System accessories. The order of single-use sterile instruments includes introducers, temperature probes, and unique, non-cooled laser applicators that will be used to assess the clinical utility of the company?s TRANBERG Thermal Therapy System towards MRI/Ultrasound fusion-guided focal laser ablation (FLA) of prostate tissue and prostate cancer in male patients. The order falls under the research collaboration agreement between NIH and CLS that was launched in April 2023.

Focal laser ablation of prostate tumors has demonstrated high levels of precision and accuracy with low risk of side effects, such as erectile dysfunction and urinary incontinence.